Study identifies biomarker that could predict whether colon cancer patients benefit from chemotherapy
Many people with stage II or III colon cancer receive additional, or adjuvant, chemotherapy following…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
First-in-class breast cancer drug approved
The Institute of Cancer Research, London, UK, welcomes the news that a new targeted breast…
Study uncovers key immune cells for combating aggressive Merkel cell carcinoma
Merkel cell carcinoma is a rare but highly aggressive form of skin cancer known for its rapid growth…
A new drug target identified for diseases associated with leukaemia-causing virus
A team of researchers from Penn State College of Medicine, USA, found a new target…
Team marks milestone in progress toward investigational new drug for triple-negative breast cancer
A new compound developed by researchers at MUSC Hollings Cancer Center, USA, shows promise in…
Taking a closer look at eye cancer: Research offers new insight into high rate of metastasis
New research from Edith Cowan University (ECU) is one step closer to understanding why uveal…
Prostate cancer blood test equally effective across ethnic groups
Stockholm3, a prostate cancer test developed in Sweden, runs a combination of protein and genetic…
When tumours collide: Analysis of mixed-type breast cancer reveals complexity
As part of a breast cancer diagnosis, pathologists take cells from a biopsy and check…
Progress and challenges in RET-targeted cancer therapy
Xueqing Hu , Ujjwol Khatri , Tao Shen , and Jie Wu, at University of…
Cancer costs for Americans with private health insurance rose after the ACA rollout and fell for those with Medicaid
Olajumoke Olateju, University of Houston Low-income Americans ages 18 to 64 with cancer saved about…